Posts by Weitz and Luxenberg, P.C.
Weitz & Luxenberg to Probe Lenovo Superfish Malware Damage Claims
NEW YORK, N.Y., Feb. 24, 2015 (SEND2PRESS NEWSWIRE) -- A security expert's discovery last month that certain Lenovo laptop computers were shipped with well-concealed malware giving hackers easy access to users' most confidential information has led Weitz and Luxenberg P.C. to announce an investigation into potential legal claims against the hardware manufacturer and against the malware vendor, Superfish, the law firm today disclosed.
Anthem Data Breach Sparks Class Action Lawsuit, Weitz & Luxenberg Announces
LOS ANGELES, Calif., Feb. 18, 2015 (SEND2PRESS NEWSWIRE) -- Weitz and Luxenberg, P.C., today announced the filing of a class action lawsuit against the nation's second-largest health insurer, Indianapolis-based Anthem Inc., following disclosure earlier this month that the private information of 80 million Anthem customers was stolen in a massive online data breach.
Weitz & Luxenberg’s Relkin Appointed to Xarelto MDL Leadership Team
NEW YORK, N.Y., Feb. 11, 2015 (SEND2PRESS NEWSWIRE) -- Ellen Relkin, of counsel attorney with Weitz and Luxenberg, P.C., has been named to the plaintiffs' steering committee created by judicial order to facilitate lawsuits against the makers of the anticoagulant drug Xarelto, the personal injury and mass tort law firm today announced.
National Law Journal Names Weitz and Luxenberg to ‘Elite Trial Lawyers’ List, Reveals 2 Keys to Firm’s $9-Billion Actos Verdict
NEW YORK, N.Y., Oct. 1, 2014 (SEND2PRESS NEWSWIRE) -- Two keys that earlier this year led to a $9-billion courtroom victory by Weitz and Luxenberg, P.C., against the maker of the diabetes drug Actos, were revealed Monday when National Law Journal named the New York City-based personal injury firm to its debut list of 'America's Elite Trial Lawyers.'